ATR and neoplasm: Moreover, the ATM/ATR inhibitor VE-822 sensitized xenograft tumors to etoposide treatment (Fig. 6g–i), and analysis of tumor sections showed that VE-822 decreased the frequency of centrosome clustering (Fig. 6j).